What causes granuloma formation after mesotherapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Granuloma Formation After Mesotherapy

Granuloma formation after mesotherapy is primarily caused by foreign body reactions to injected substances, infection with atypical mycobacteria, and improper injection techniques. 1, 2, 3

Foreign Body Reactions

  • Foreign body-type granulomatous reactions occur when the immune system responds to injected substances that are recognized as foreign materials 1
  • Unauthorized or unapproved substances used in mesotherapy solutions are a major risk factor for granuloma development 1, 3
  • Dermal fillers and other injectable materials can trigger granuloma formation after a latent period of several months, typically appearing at all injected sites simultaneously 4
  • Lipolytic cocktails used for fat reduction mesotherapy have been specifically associated with cutaneous foreign body granulomas 3

Infectious Causes

  • Atypical mycobacterial infections, particularly with species like Mycobacterium massiliense, are significant causes of granuloma formation after mesotherapy 2
  • These infections can be difficult to diagnose through standard cultures and often require molecular diagnostic techniques for proper identification 2
  • Contaminated solutions, equipment, or inadequate skin preparation can introduce mycobacteria during the procedure 2, 5
  • Bacterial infections may not only cause granulomas directly but can also trigger foreign body granulomas in patients with previously injected fillers 4

Technical and Procedural Factors

  • Improper injection techniques including incorrect depth, volume, or distribution of injected materials can contribute to granuloma formation 6
  • Excessive concentration of injected substances can increase the risk of granulomatous reactions 7, 6
  • Repeated injections in the same area may increase the likelihood of granuloma development 6
  • Unlicensed practitioners performing mesotherapy significantly increase the risk of adverse reactions including granulomas 5

Patient-Related Factors

  • Individual immune system responses vary, with some patients being more susceptible to granulomatous reactions 4
  • Pre-existing inflammatory skin conditions may predispose patients to granuloma formation 6
  • History of previous hypersensitivity reactions to injectable substances increases risk 6

Prevention Strategies

  • Only licensed practitioners should perform mesotherapy using FDA-approved substances 5
  • Proper sterilization techniques and adherence to safe injection practices are essential 5
  • Appropriate dilution of active substances and careful selection of injection sites can minimize risk 7, 6
  • Thorough patient screening for history of hypersensitivity reactions or autoimmune disorders is recommended 6

Management of Established Granulomas

  • Intralesional injection of corticosteroid crystals (triamcinolone, betamethasone, or prednisolone) is the first-line treatment for foreign body granulomas 4
  • Corticosteroids can be combined with antimitotic drugs such as 5-fluorouracil to reduce the risk of skin atrophy 4
  • For infected granulomas, appropriate antimicrobial therapy directed at the specific pathogen is essential 2
  • Surgical excision should be considered only as a last resort due to the fingerlike growth pattern of granulomas into surrounding tissue 4

Understanding these causes is crucial for both prevention and appropriate management of granulomatous reactions after mesotherapy.

References

Research

Cutaneous foreign body granulomas associated with lipolytic cocktail: Who is the enemy, mesotherapy or drugs injected?

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2017

Guideline

Management of Inflammatory Granulation Tissue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypergranulation Tissue with Active Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.